Skip navigation

Refine by Type

Results 1 - 10 of 30 for SUNITINIB
  1. Sunitinib is used to treat gastrointestinal stromal tumors (GIST; a type of tumor that grows in the ... imatinib (Gleevec) or people who cannot take imatinib. Sunitinib is also used to treat advanced renal cell ...
  2. Targeted Therapies for Kidney Cancer (American Cancer Society)  
    ... or soles of the feet (hand-foot syndrome). Sunitinib (Sutent ® ) Sunitinib also blocks several tyrosine kinases, but not the ... cancers after other drugs such as sorafenib or sunitinib have been tried. Everolimus is taken as a ...
  3. ... or if the side effects are too severe, sunitinib (Sutent) may be tried instead. If sunitinib is no longer working, the targeted drug regorafenib ( ... from imatinib are too severe, a switch to sunitinib may be helpful. If sunitinib is no longer ...
  4. ... with imatinib-resistant tumors are then treated with sunitinib (Sutent®), but the disease usually develops resistance to sunitinib and progresses within 1 year. Patients with advanced ...
  5. ... thyroid cancer in clinical trials include sorafenib (Nexavar ® ), sunitinib (Sutent ® ), pazopanib (Votrient ® ), cabozantinib (Cometriq), motesanib (AMG 706), ... of the disease. Some other TKIs, such as sunitinib, sorafenib, and pazopanib, are already approved to treat ...
  6. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... Cetuximab (Erbitux®) Gastrointestinal stromal tumor: Imatinib mesylate (Gleevec®) , Sunitinib (Sutent®) , Regorafenib (Stivarga®) Giant cell tumor of the ... Alitretinoin (Panretin®) Kidney cancer: Bevacizumab (Avastin®) , Sorafenib ... Pazopanib (Votrient®) , Temsirolimus (Torisel®) , Everolimus (Afinitor®) , Axitinib ( ...
  7. Angiogenesis Inhibitors From the National Institutes of Health (National Cancer Institute)  
    ... VEGF receptor. Other angiogenesis inhibitors, including sorafenib and sunitinib, bind to receptors on the surface of endothelial ... drugs that have antiangiogenic activity, including sorafenib ( Nexavar ®), sunitinib ( Sutent ®), pazopanib ( Votrient ®), and everolimus ( Afinitor ®). Sorafenib is ...
  8. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Sterile Talc Powder (Talc) Steritalc (Talc) Stivarga (Regorafenib) Sunitinib Malate Sutent (Sunitinib Malate) Sylatron (Peginterferon Alfa-2b) Sylvant (Siltuximab) Synovir ( ...
  9. Drugs Approved for Soft Tissue Sarcoma From the National Institutes of Health (National Cancer Institute)  
    ... Gleevec (Imatinib Mesylate) Imatinib Mesylate Regorafenib Stivarga (Regorafenib) Sunitinib Malate Sutent (Sunitinib Malate) Drugs Approved for Rhabdomyosarcoma ...
  10. Drugs Approved for Pancreatic Cancer From the National Institutes of Health (National Cancer Institute)  
    ... Mutamycin (Mitomycin C) Paclitaxel Albumin-stabilized Nanoparticle Formulation Sunitinib Malate Sutent (Sunitinib Malate) Tarceva (Erlotinib Hydrochloride) Drug ...
previous · 1 · 2 · 3 · next